Antisense mapping of opioid receptor clones: effects upon 2-deoxy-D-glucose-induced hyperphagia

Brain Res. 1998 Jun 1;794(2):359-63. doi: 10.1016/s0006-8993(98)00331-x.

Abstract

Antisense oligodeoxynucleotides (AS ODNs) directed against exons 1 and 2 of the MOR-1 clone significantly and markedly reduced (81-93%) hyperphagia induced by the anti-metabolic glucose analogue, 2-deoxy-d-glucose (2DG) across a 4 h time course. AS ODNs directed against exons 3 or 4 of the MOR-1 clone had a more limited (1-2 h) duration of action upon 2DG-induced hyperphagia. 2DG-induced hyperphagia was significantly reduced by AS ODNs directed against exon 2 (44-51%), but not exons 1 or 3 of the KOR-1 clone across a 4 h time course. Whereas an AS ODN probe directed against the KOR3/ORL-1 clone produced small (36%), but significant reductions in 2DG-induced hyperphagia, an AS ODN probe directed against the DOR-1 clone was ineffective. These data provide further converging evidence for the roles of primarily mu, but also kappa1 and kappa3 opioid receptors in mediating the hyperphagic effects of glucoprivation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cloning, Molecular
  • Deoxyglucose
  • Exons
  • Hyperphagia / chemically induced*
  • Male
  • Oligonucleotides, Antisense*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid / analysis*

Substances

  • Oligonucleotides, Antisense
  • Receptors, Opioid
  • Deoxyglucose